COL19A1 and amyotrophic lateral sclerosis: Furthermore, the remarkable difference in COL19A1 gene and protein levels observed in the ALS patients respect to the ONP group also suggested that COL19A1 could be involved in specific muscle defects that could enhance the desestabilization of motor neuron terminals, contributing especially to the neurodegenerative progression in ALS.